Medicare Part B Costs Are Rising in 2025 and Going to Deal Retirees a Double Whammy
Currently, the standard monthly Medicare Part B premium is $174.70. In 2025, it's rising to $185. That's an increase of ...
What are the Medicare premiums and costs in 2025?
The standard monthly Part B premium will be $185 in 2025, up from $174.70 this year, the Centers for Medicare and Medicaid ...
The Sickest Patients Are Fleeing Private Medicare Plans—Costing Taxpayers Billions
Patricia Greene had spent a month recovering from a devastating stroke when her Medicare Advantage insurer, a unit of ...
2025 Medicare Part B premium increase outpaces both Social Security COLA and inflation
Medicare Part B premiums are rising again in 2025. The jump outpaces both Social Security's 2025 COLA and inflation, further ...
Healthline2 小时
5 Changes to Medicare in 2025 Will Affect Part D Coverage, Drug Costs
In 2025, an annual $2,000 out-of-pocket cap will keep costs low for Medicare enrollees on drugs covered by Part D plans. A ...
Forbes51 分钟
In-Person, Online With Today’s Medicare Beneficiaries
In a focus group this past spring, seniors gave it to us straight: When you’re making an important decision like choosing ...
OPINION | Feldman: Avoid Medicare Advantage programs
The majority of Medicare patients opt into Medicare Advantage programs, considering them more affordable with lower premiums.
Probably No Surprise: Medicare Part B Will Cost More In 2025
On November 8, the Centers for Medicare and Medicaid Services announced the Medicare premiums and costs for 2025. Let’s take ...
美国医疗保障体系的前世今生：从Medicare到奥巴马医保，你了解多少？
回顾历史，Medicare是在1965年由时任总统林登·约翰逊签署成为法律的，它最初是为65岁及以上的老年人提供医疗保险。这一举措标志着美国政府在社会保障领域迈出了重要一步。随着时间的推移，Medicare逐渐扩展，涵盖了更多的人群和服务项目，如残疾人士和某些长期病患者。如今，Medicare已成为美国最大的公共医疗保险计划之一，分为Part A（住院保险）、Part B（医疗保险）、Part C ...
How eHealth improved the often-dreaded process of choosing a Medicare plan
The “Your Medicare Matchmaker” campaign aimed to empower consumers and inform them about their coverage options.
Buffalo News4 小时Opinion
Another Voice: Medicare open enrollment period still bedeviling
According to KFF research, senior citizens are presented with confusing, predatory, and misleading marketing for so-called ...
Medicare扩大淋巴瘤MRD检测的覆盖范围
西雅图 - Adaptive Biotechnologies Corporation (NASDAQ:ADPT)今日宣布,其clonoSEQ检测获得Medicare承包商Palmetto GBA的扩大覆盖范围,将包括患有套细胞淋巴瘤(MCL)的Medicare患者。这一决定允许对这类患者进行可测量残留病变(MRD)的检测和监测。 MCL是非霍奇金淋巴瘤的一种亚型,在美国每年约有4,000例新病例。